PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis
- 28 April 2005
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 104 (3) , 447-460
- https://doi.org/10.1016/j.jconrel.2005.02.020
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.Pharmaceutical Research, 2004
- Control of encapsulation efficiency and initial burst in polymeric microparticle systemsArchives of Pharmacal Research, 2004
- Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF RatsPharmaceutical Research, 2003
- Lifetime Risk for Diabetes Mellitus in the United StatesJAMA, 2003
- Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheresInternational Journal of Pharmaceutics, 2003
- A novel sustained-release formulation of insulin with dramatic reduction in initial rapid releaseJournal of Controlled Release, 2002
- Synthesis and Characterization of Poly(ethylene glycol)−Insulin ConjugatesBioconjugate Chemistry, 2000
- Stabilization of pH-Induced Degradation of Porcine Insulin in Biodegradable Polyester MicrospheresPharmaceutical Development and Technology, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993